344 related articles for article (PubMed ID: 34120803)
1. Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenocarcinoma: A case report.
Doty DG; Chuong MD; Gomez AG; Bryant J; Contreras J; Romaguera T; Alvarez D; Kotecha R; Mehta MP; Gutierrez AN; Mittauer KE
Med Dosim; 2021 Winter; 46(4):384-388. PubMed ID: 34120803
[TBL] [Abstract][Full Text] [Related]
2. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR).
Kim M; Schiff JP; Price A; Laugeman E; Samson PP; Kim H; Badiyan SN; Henke LE
Radiat Oncol; 2022 Sep; 17(1):157. PubMed ID: 36100866
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.
Henke L; Kashani R; Robinson C; Curcuru A; DeWees T; Bradley J; Green O; Michalski J; Mutic S; Parikh P; Olsen J
Radiother Oncol; 2018 Mar; 126(3):519-526. PubMed ID: 29277446
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
[TBL] [Abstract][Full Text] [Related]
5. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
6. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
[TBL] [Abstract][Full Text] [Related]
7. Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer.
Bohoudi O; Bruynzeel AME; Senan S; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Palacios MA
Radiother Oncol; 2017 Dec; 125(3):439-444. PubMed ID: 28811038
[TBL] [Abstract][Full Text] [Related]
8. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
[TBL] [Abstract][Full Text] [Related]
10. MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
Pavic M; Niyazi M; Wilke L; Corradini S; Vornhülz M; Mansmann U; Al Tawil A; Fritsch R; Hörner-Rieber J; Debus J; Guckenberger M; Belka C; Mayerle J; Beyer G
Radiat Oncol; 2022 Jan; 17(1):18. PubMed ID: 35078490
[TBL] [Abstract][Full Text] [Related]
11. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
[TBL] [Abstract][Full Text] [Related]
13. Linac-based stereotactic body radiation therapy for unresectable locally advanced pancreatic cancer: risk-adapted dose prescription and image-guided delivery.
Mazzola R; Fersino S; Aiello D; Gregucci F; Tebano U; Corradini S; Di Paola G; Cirillo M; Tondulli L; Ruffo G; Ruggieri R; Alongi F
Strahlenther Onkol; 2018 Sep; 194(9):835-842. PubMed ID: 29696321
[TBL] [Abstract][Full Text] [Related]
14. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
Parikh PJ; Lee P; Low DA; Kim J; Mittauer KE; Bassetti MF; Glide-Hurst CK; Raldow AC; Yang Y; Portelance L; Padgett KR; Zaki B; Zhang R; Kim H; Henke LE; Price AT; Mancias JD; Williams CL; Ng J; Pennell R; Pfeffer MR; Levin D; Mueller AC; Mooney KE; Kelly P; Shah AP; Boldrini L; Placidi L; Fuss M; Chuong MD
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):799-808. PubMed ID: 37210048
[TBL] [Abstract][Full Text] [Related]
15. Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy.
Wang S; Zheng D; Lin C; Lei Y; Verma V; Smith A; Ma R; Enke CA; Zhou S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819851520. PubMed ID: 31195891
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study.
Chuong MD; Lee P; Low DA; Kim J; Mittauer KE; Bassetti MF; Glide-Hurst CK; Raldow AC; Yang Y; Portelance L; Padgett KR; Zaki B; Zhang R; Kim H; Henke LE; Price AT; Mancias JD; Williams CL; Ng J; Pennell R; Raphael Pfeffer M; Levin D; Mueller AC; Mooney KE; Kelly P; Shah AP; Boldrini L; Placidi L; Fuss M; Jitendra Parikh P
Radiother Oncol; 2024 Feb; 191():110064. PubMed ID: 38135187
[TBL] [Abstract][Full Text] [Related]
18. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
[TBL] [Abstract][Full Text] [Related]
19. Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy.
Bohoudi O; Bruynzeel AME; Meijerink MR; Senan S; Slotman BJ; Palacios MA; Lagerwaard FJ
Radiother Oncol; 2019 Mar; 132():16-22. PubMed ID: 30825964
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis.
Boldrini L; Romano A; Chiloiro G; Corradini S; De Luca V; Verusio V; D'Aviero A; Castelluccia A; Alitto AR; Catucci F; Grimaldi G; Trapp C; Hörner-Rieber J; Marchesano D; Frascino V; Mattiucci GC; Valentini V; Gentile P; Gambacorta MA
Radiat Oncol; 2023 May; 18(1):84. PubMed ID: 37218005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
